Jamshid Hadjati

Citée par

	Toutes	Depuis 2020
Citations	3656	2266
indice h	37	28
indice i10	80	61

500

250

125

375

20052006200720082009201020112012201320142015201620172018201920202021202220232024202511 13 8 23 55 42 49 35 51 79 107 164 172 237 324 443 492 454 383 451 42

Accès public

Tout afficher

17 articles

3 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Hamid Reza Mirzaei, PhDSenior Research Scientist at Memorial Sloan Kettering Cancer CenterAdresse e-mail validée de mskcc.org
samaneh arabDepartment of Tissue Engineering and Applied Cell Sciences, Semnan University of Medical SciencesAdresse e-mail validée de semums.ac.ir
Reza MirzaeiMemorial Sloan Kettering Cancer CenterAdresse e-mail validée de ualberta.ca
Maryam AjamiPhD at Tarbiat Modares UniversityAdresse e-mail validée de modares.ac.ir
S.M. MoazzeniDepartment of Immunology, Tarbiat Modares UniversityAdresse e-mail validée de modares.ac.ir
maryam nourizadehImmunology, Asthma and Allergy Research InstituteAdresse e-mail validée de sina.tums.ac.ir
Afshin NamdarResearch ScientistAdresse e-mail validée de sickkids.ca
Arezoo JamaliPaul Ehrlich InstituteAdresse e-mail validée de pei.de
Farimah MasoumiAssistant Professor of Immunology, School of Medicine, Tonekabon Branch, Islamic Azad UniversityAdresse e-mail validée de toniau.ac.ir
jafar AiTissue Engineering and Applied Cell Sciences Department-School of Advanced Technologies in MedicineAdresse e-mail validée de tums.ac.ir
Dr. Mahmoud Azami(Associate profes...Tissue engineering department, Tehran University of Medical SciencesAdresse e-mail validée de tums.ac.ir
Abbas RezaeiIsfahan University of Medical SciencesAdresse e-mail validée de mui.ac.ir
Arash MemarnejadianPasteur Institute, Uni of Western Ontario, Sernova Corp.Adresse e-mail validée de sernova.com
Nima RezaeiTehran University of Medical Sciences; Universal Scientific Education and Research Network (USERN)Adresse e-mail validée de tums.ac.ir
Amirhossein SahebkarMashhad University of Medical SciencesAdresse e-mail validée de mums.ac.ir
Rasoul SalehiIsfahan University of Medical SciencesAdresse e-mail validée de med.mui.ac.ir
Marzieh ebrahimiRoyanAdresse e-mail validée de royaninstitute.org
Azad SaeiDepartment of Medicine, Karolinska InstitutetAdresse e-mail validée de parexel.com
Ali MemarianGolestan University of Medical SciencesAdresse e-mail validée de goums.ac.ir
Mehdi FarokhiNational Cell Bank of Iran, Pasteur Institute of Iran, Tehran, IranAdresse e-mail validée de pasteur.ac.ir

Suivre

Jamshid Hadjati

Autres nomsJamshid Hajati

Professor of Immunology, School of Medicine, Tehran University of Medical Sciences

Adresse e-mail validée de tums.ac.ir

Immunology Tumor Immunotherapy


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice F Jadidi-Niaragh, F Atyabi, A Rastegari, N Kheshtchin, S Arab, ... Journal of Controlled Release 246, 46-59, 2017	173	2017
Epi-drugs and Epi-miRs: moving beyond current cancer therapies R Salarinia, A Sahebkar, M Peyvandi, H Reza Mirzaei, M Reza Jaafari, ... Current cancer drug targets 16 (9), 773-788, 2016	138	2016
Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy HR Mirzaei, H Mirzaei, SY Lee, J Hadjati, BG Till Cancer letters 380 (2), 413-423, 2016	138	2016
Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin C Lane, J Leitch, X Tan, J Hadjati, JL Bramson, Y Wan Cancer research 64 (4), 1509, 2004	106	2004
Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications M Mirahmadian, N Parvaneh, A Salavati, S Abdollahzade, N Rezaei, ... J Investig Allergol Clin Immunol 17 (5), 321-328, 2007	102	2007
Application of mesenchymal stem cells in melanoma: a potential therapeutic strategy for delivery of targeted agents H Mirzaei, A Sahebkar, A Avan, M R Jaafari, R Salehi, H Salehi, ... Current Medicinal Chemistry 23 (5), 455-463, 2016	101	2016
Prolonged persistence of chimeric antigen receptor (CAR) T cell in adoptive cancer immunotherapy: challenges and ways forward L Jafarzadeh, E Masoumi, K Fallah-Mehrjardi, HR Mirzaei, J Hadjati Frontiers in immunology 11, 702, 2020	99	2020
Bio-hybrid silk fibroin/calcium phosphate/PLGA nanocomposite scaffold to control the delivery of vascular endothelial growth factor M Farokhi, F Mottaghitalab, MA Shokrgozar, J Ai, J Hadjati, M Azami Materials Science and Engineering: C 35, 401-410, 2014	96	2014
Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer N Kheshtchin, S Arab, M Ajami, R Mirzaei, M Ashourpour, N Mousavi, ... Cancer Immunology, Immunotherapy 65, 1159-1167, 2016	93	2016
Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles F Jadidi-Niaragh, F Atyabi, A Rastegari, E Mollarazi, M Kiani, A Razavi, ... Tumor Biology 37, 8403-8412, 2016	89	2016
Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor S Arab, N Kheshtchin, M Ajami, M Ashurpoor, A Safvati, A Namdar, ... Tumor Biology 39 (3), 1010428317695021, 2017	80	2017
Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells E Masoumi, L Jafarzadeh, HR Mirzaei, K Alishah, K Fallah-Mehrjardi, ... Journal of Experimental & Clinical Cancer Research 39, 1-12, 2020	77	2020
Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses A Dashti, M Ebrahimi, J Hadjati, A Memarnejadian, SM Moazzeni Cancer letters 374 (1), 175-185, 2016	76	2016
Adenosine blockage in tumor microenvironment and improvement of cancer immunotherapy S Arab, J Hadjati Immune network 19 (4), 2019	74	2019
Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice K Amirshahrokhi, AR Dehpour, J Hadjati, M Sotoudeh, M Ghazi-Khansari Toxicology and applied pharmacology 232 (1), 119-124, 2008	73	2008
Anti‐angiogenic effects of CD73‐specific siRNA‐loaded nanoparticles in breast cancer‐bearing mice G Ghalamfarsa, A Rastegari, F Atyabi, H Hassannia, M Hojjat‐Farsangi, ... Journal of cellular physiology 233 (10), 7165-7177, 2018	71	2018
Upregulation of CD200 is associated with Foxp3⁺ regulatory T cell expansion and disease progression in acute myeloid leukemia A Memarian, M Nourizadeh, F Masoumi, M Tabrizi, AH Emami, ... Tumor Biology 34, 531-542, 2013	70	2013
Gene-knocked out chimeric antigen receptor (CAR) T cells: tuning up for the next generation cancer immunotherapy HR Mirzaei, H Pourghadamyari, M Rahmati, A Mohammadi, JS Nahand, ... Cancer letters 423, 95-104, 2018	62	2018
Highly efficient generation of transgenically augmented CAR NK cells overexpressing CXCR4 A Jamali, J Hadjati, Z Madjd, HR Mirzaei, FB Thalheimer, S Agarwal, ... Frontiers in immunology 11, 2028, 2020	60	2020
An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol M Qomlaqi, F Bahrami, M Ajami, J Hajati Mathematical biosciences 292, 1-9, 2017	56	2017

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs